相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variegated RHOA mutations in adult T-cell leukemia/lymphoma
Yasunobu Nagata et al.
BLOOD (2016)
RHOA mutation may be associated with diffuse-type gastric cancer progression, but is it gain or loss?
Masahiro Maeda et al.
GASTRIC CANCER (2016)
Clinicopathological characteristics of RHOA mutations in a Central European gastric cancer cohort
Christoph Roecken et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Yangbo Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells
M. O'Hayre et al.
ONCOGENE (2016)
Novel Insights into the Roles of Rho Kinase in Cancer
Lei Wei et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Opposite RHOA functions within the ATLL category
Shumpei Ishikawa
BLOOD (2016)
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Rebecca L. Boddicker et al.
BLOOD (2016)
Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers
Campbell D. Lawson et al.
CANCER RESEARCH (2016)
Temporal-specific roles of Rac1 during vascular development and retinal angiogenesis
Nijiro Nohata et al.
DEVELOPMENTAL BIOLOGY (2016)
Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression
Pauline Croise et al.
ENDOCRINE-RELATED CANCER (2016)
Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers
Ana I. Robles et al.
GASTROENTEROLOGY (2016)
A combinatorial strategy for treating KRAS-mutant lung cancer
Eusebio Manchado et al.
NATURE (2016)
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell et al.
NATURE GENETICS (2016)
Unsupervised detection of cancer driver mutations with parsimony-guided learning
Runjun D. Kumar et al.
NATURE GENETICS (2016)
Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma
Yonathan Lissanu Deribe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK
Jieqiong Wang et al.
NATURE COMMUNICATIONS (2016)
Rho-associated kinase(ROCK)function is essential for cell cycle progression, senescence and tumorigenesis
Sandra Kuemper et al.
ELIFE (2016)
Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention
Annapurna Pranatharthi et al.
STEM CELLS INTERNATIONAL (2016)
Rho regulation: DLC proteins in space and time
Anja C. Braun et al.
CELLULAR SIGNALLING (2015)
Approaches of targeting Rho GTPases in cancer drug discovery
Yuan Lin et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Integrated molecular analysis of adult T cell leukemia/lymphoma
Keisuke Kataoka et al.
NATURE GENETICS (2015)
A role for Rac1 activity in malignant progression of sebaceous skin tumors
D. Frances et al.
ONCOGENE (2015)
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK
Celia J. Vogel et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice
Inuk Zandvakili et al.
PLOS ONE (2015)
p21-activated kinase family: promising new drug targets
Nhi Huynh et al.
RESEARCH AND REPORTS IN BIOCHEMISTRY (2015)
The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature
Rebeca Manso et al.
BLOOD (2014)
Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
M. Holderfield et al.
BRITISH JOURNAL OF CANCER (2014)
Targeting Rho-GTPases in immune cell migration and inflammation
Mate Biro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
RhoA Mutations Identified in Diffuse Gastric Cancer
Jin Zhou et al.
CANCER CELL (2014)
The RhoGEF GEF-H1 Is Required for Oncogenic RAS Signaling via KSR-1
Jane Cullis et al.
CANCER CELL (2014)
CDC42 Inhibition Suppresses Progression of Incipient Intestinal Tumors
Ryotaro Sakamori et al.
CANCER RESEARCH (2014)
The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
Ian R. Watson et al.
CANCER RESEARCH (2014)
Recurrent RHOA Mutations in Pediatric Burkitt Lymphoma Treated According to the NHL-BFM Protocols
Marius Rohde et al.
GENES CHROMOSOMES & CANCER (2014)
RhoB Promotes Cancer Initiation by Protecting Keratinocytes from UVB-Induced Apoptosis but Limits Tumor Aggressiveness
Nicolas Meyer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition
Wei Zhou et al.
JOURNAL OF PATHOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma
Miwako Kakiuchi et al.
NATURE GENETICS (2014)
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
Hae Yong Yoo et al.
NATURE GENETICS (2014)
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Mamiko Sakata-Yanagimoto et al.
NATURE GENETICS (2014)
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Teresa Palomero et al.
NATURE GENETICS (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models
T. W. Chew et al.
ONCOGENE (2014)
Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease
D. R. Cook et al.
ONCOGENE (2014)
RHOA inactivation enhances Wnt signalling and promotes colorectal cancer
Paulo Rodrigues et al.
NATURE COMMUNICATIONS (2014)
RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
Ralph Fritsch et al.
CELL (2013)
RAC1b overexpression in papillary thyroid carcinoma: a role to unravel
Ana Luisa Silva et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Cdc42 Coordinates Proliferation, Polarity, Migration, and Differentiation of Small Intestinal Epithelial Cells in Mice
Jaime Melendez et al.
GASTROENTEROLOGY (2013)
Cell Type-specific Signaling Function of RhoA GTPase: Lessons from Mouse Gene Targeting
Xuan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of ROCK Activity in Cancer
Marie Morgan-Fisher et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
RhoA, RhoB and RhoC have different roles in cancer cell migration
A. J. Ridley
JOURNAL OF MICROSCOPY (2013)
The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis
C. Zhou et al.
ONCOGENE (2013)
REGULATION OF SMALL GTPases BY GEFs, GAPs, AND GDIs
Jacqueline Cherfils et al.
PHYSIOLOGICAL REVIEWS (2013)
Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors
Xun Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
Georgia Konstantinidou et al.
CANCER DISCOVERY (2013)
Rho family GTPases
Alan Hall
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model
Hoi Yee Chow et al.
CANCER RESEARCH (2012)
The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
Madhu S. Kumar et al.
CELL (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation
Maria Carolina Florian et al.
CELL STEM CELL (2012)
Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases
Xun Shang et al.
CHEMISTRY & BIOLOGY (2012)
Rational Design of Small Molecule Inhibitors Targeting the Rac GTPase-p67Phox Signaling Axis in Inflammation
Emily E. Bosco et al.
CHEMISTRY & BIOLOGY (2012)
Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy
Nicola Rath et al.
EMBO REPORTS (2012)
The Ras protein superfamily: Evolutionary tree and role of conserved amino acids
Ana Maria Rojas et al.
JOURNAL OF CELL BIOLOGY (2012)
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
Patrick A. Oberholzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cooperative Activation of PI3K by Ras and Rho Family Small GTPases
Hee Won Yang et al.
MOLECULAR CELL (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Essential Role of Cdc42 in Ras-Induced Transformation Revealed by Gene Targeting
Kristy R. Stengel et al.
PLOS ONE (2012)
Rho GEFs and Cancer: Linking Gene Expression and Metastatic Dissemination
Laura Barrio-Real et al.
SCIENCE SIGNALING (2012)
Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia
Benjamin Mizukawa et al.
BLOOD (2011)
Identification of Novel Ras-Cooperating Oncogenes in Drosophila melanogaster: A RhoGEF/Rho-Family/JNK Pathway Is a Central Driver of Tumorigenesis
Anthony M. Brumby et al.
GENETICS (2011)
Cancer Drug-Resistance and a Look at Specific Proteins: Rho GDP-Dissociation Inhibitor 2, Y-Box Binding Protein 1, and HSP70/90 Organizing Protein in Proteomics Clinical Application
Helena Skalnikova et al.
JOURNAL OF PROTEOME RESEARCH (2011)
The 'invisible hand': regulation of RHO GTPases by RHOGDIs
Rafael Garcia-Mata et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
K-Ras Mediated Murine Epidermal Tumorigenesis Is Dependent upon and Associated with Elevated Rac1 Activity
Michael S. Samuel et al.
PLOS ONE (2011)
Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression
Philippe Riou et al.
BIOESSAYS (2010)
Rac and Rho GTPases in cancer cell motility control
Matteo Parri et al.
CELL COMMUNICATION AND SIGNALING (2010)
Pleiotropic Functions of Rho GTPase Signaling: A Trojan Horse or Achilles' Heel for Breast Cancer Treatment?
P. R. McHenry et al.
CURRENT DRUG TARGETS (2010)
RhoGDI signaling provides targets for cancer therapy
Michael A. Harding et al.
EUROPEAN JOURNAL OF CANCER (2010)
Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma
Liang Zhao et al.
FEBS JOURNAL (2010)
Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo
Z. Wang et al.
ONCOGENE (2010)
Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC
T. M. Kitzing et al.
ONCOGENE (2010)
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Dominico Vigil et al.
NATURE REVIEWS CANCER (2010)
Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1
Emilie Bousquet et al.
CANCER RESEARCH (2009)
Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations
Hannah Carter et al.
CANCER RESEARCH (2009)
RhoA Regulates G(1)-S Progression of Gastric Cancer Cells by Modulation of Multiple INK4 Family Tumor Suppressors
Siyuan Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Consensus transcriptome signature of perineural invasion in pancreatic carcinoma
Ivane Abiatari et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a
Barry Fine et al.
SCIENCE (2009)
High-Throughput Screening for Small-Molecule Inhibitors of LARG-Stimulated RhoA Nucleotide Binding via a Novel Fluorescence Polarization Assay
Chris R. Evelyn et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression
Brandy M. Heckman-Stoddard et al.
BREAST CANCER RESEARCH (2009)
Rho GTPases in cancer cell biology
Francisco M. Vega et al.
FEBS LETTERS (2008)
B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival
Paulo Matos et al.
GASTROENTEROLOGY (2008)
Continuous cell injury promotes hepatic tumorigenesis in Cdc42-deficient mouse liver
Jolanda Van Hengel et al.
GASTROENTEROLOGY (2008)
Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer
Liang Zhao et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Mammalian Rho GTPases:: new insights into their functions from in vivo studies
Sarah J. Heasman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis
Linda Yang et al.
BLOOD (2007)
Vasopressin triggers senescence in K-ras transformed cells via RhoA-dependent downregulation of cyclin D1
Fabio L. Forti et al.
ENDOCRINE-RELATED CANCER (2007)
Taking Rho GTPases to the next level:: The cellular functions of atypical Rho GTPases
Pontus Aspenstrom et al.
EXPERIMENTAL CELL RESEARCH (2007)
RhoC is essential for the metastasis of gastric cancer
Na Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Requirement for Rac1 in a K-ras-induced lung cancer in the mouse
Joseph L. Kissil et al.
CANCER RESEARCH (2007)
Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina
Yoshihiro Fukumoto et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line
Naohito Sato et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo
Xose R. Bustelo et al.
BIOESSAYS (2007)
Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer
N Koide et al.
CLINICAL CANCER RESEARCH (2006)
Efficacy and safety of fasudil in patients with stable angina - A double-blind, placebo-controlled, phase 2 trial
RM Vicari et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Signaling interplay in Ras superfamily function
N Mitin et al.
CURRENT BIOLOGY (2005)
Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis
BL Zhang et al.
CANCER RESEARCH (2005)
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
DC Radisky et al.
NATURE (2005)
Targeting Ras and Rho GTPases as opportunities for cancer therapeutics
K Walker et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis
A Hakem et al.
GENES & DEVELOPMENT (2005)
Loss of RhoB expression in human lung cancer progression
J Mazieres et al.
CLINICAL CANCER RESEARCH (2004)
Rho-regulatory proteins in breast cancer cell motility and invasion
M Lin et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation
A Singh et al.
ONCOGENE (2004)
Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility
AP Wheeler et al.
EXPERIMENTAL CELL RESEARCH (2004)
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Y Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Actin dynamics control SRF activity by regulation of its coactivator MAL
F Miralles et al.
CELL (2003)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells
XF Ming et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
G Fritz et al.
BRITISH JOURNAL OF CANCER (2002)
Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism
JM Lambert et al.
NATURE CELL BIOLOGY (2002)
The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers
MA Forget et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells
AX Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines
MJ Seraj et al.
CLINICAL & EXPERIMENTAL METASTASIS (2001)
Ras and Rho GTPases: A family reunion
D Bar-Sagi et al.
CELL (2000)
分享论文
